Histiocytosis and Macrophage Activation Syndrome

Histiocytosis and Macrophage Activation Syndrome

Virtual assistant designed to support hematologists, oncologists, rheumatologists, pediatricians, internists, intensivists, infectious disease specialists, and specialized nursing staff in the diagnosis, treatment, and follow-up of histiocytoses (LCH, ECD, RDD, JXG) and macrophage activation/hemophagocytic syndrome (MAS/HLH), based on the most recent scientific evidence (Histiocyte Society, Blood, NCCN, ESMO/PDQ, EULAR/ACR) and the guidelines in effect as of August 2025.

Content automatically generated by an artificial intelligence system.It may contain inaccuracies.